Wnt signaling is a major player during development and its misregulation often leads to disease, especially cancer. The negative feedback Wnt regulator homologs, Nkd1 and Nkd2, have been shown to inhibit Wnt signaling during development, and current evidence suggests that Nkds degrade Dvl proteins to antagonize Wnt signaling. Here, we demonstrate that during early zebrafish development Nkd1 does not alter either endogenous or exogenous levels of Dvl2. Furthermore, Dvl2 does not affect the levels of Nkd1. Cumulatively, these results demonstrate that Dvl2 is a ubiquitous and stable protein and that Nkds may not always function to degrade Dvl proteins as a method of inhibiting Wnt signaling.
Introduction

D
rosophila Naked Cuticle (Nkd) and its vertebrate homologs Naked1 (Nkd1) and Naked2 (Nkd2) antagonize Wnt signaling, and recent in vitro evidence suggests that Nkds degrade Dvl, providing an effective way to shut down the pathway. [1] [2] [3] However, there are functional differences between Nkd proteins to suggest that they are not completely redundant. 4, 5 For example, Nkd2 has an additional function in epidermal growth factor receptor (EGFR) signaling. 6, 7 In contrast, Nkd1 appears specific for Wnt signaling and is more reminiscent of Drosophila Nkd, both being Wnt-induced negative regulators. 5, 8 Currently, there is no evidence that fly Nkd degrades Dvl, and there is new evidence to suggest that Nkd1 antagonizes Wnt signaling independent of Dvl. 4, 9 As Nkd and Nkd1 have been shown to bind other Dvl proteins, 4, 8, 10 we wanted to further investigate the role of Nkd1 in the stability of Dvl2. To investigate the interaction between Nkd1 and Dvl2, we used the early zebrafish embryo for which the Wnt signaling pathways and timing of Wnt signaling are well characterized. [11] [12] [13] To investigate endogenous Dvl2, a polyclonal antibody to zebrafish Dvl2 was generated. In contrast to recent findings, [1] [2] [3] this study demonstrates that during early zebrafish development Dvl2 is a stable protein and is not involved in hastening the degradation of Nkd1. Nkd1 also does not increase the degradation rate of either endogenous or exogenous Dvl2.
Results
Characterization of anti-Dvl2 antibody
To investigate the role of endogenous Dvl2, a polyclonal antibody to zebrafish Dvl2 was generated. The epitope was designed in a nonconserved region of Dvl2 and is not predicted to cross react with Dvl1 or Dvl3 (Fig. 1A) , although this has not been formally tested. Affinity-purified polyclonal anti-Dvl2 can detect both exogenous and endogenous Dvl2 proteins when used as low as 1:20,000 for western analysis (Fig. 1B) . Knockdown of endogenous Dvl2 with translation blocking antisense oligonucleotide morpholinos (MO) was observed with the antibody, confirming that the antibody can detect endogenous Dvl2 (Fig. 1C, D) . To determine if the antibody could detect exogenous Dvl2 by immunohistochemistry, Dvl2
HA was injected into one of four blastomeres to generate mosaic Dvl2 HA expression. The antibody could detect Dvl2
HA at a dilution of 1:5000 with similar, but weaker staining in non-Dvl2 HA -expressing cells (Fig. 1F, I ). The HA and the Dvl2 antibodies give nearly identical staining patterns and detect cellular puncta, which is characteristic of Dvl staining and is very similar to Drosophila Dsh and mammalian Dvl2 proteins.
14-17 At a higher concentration (1:1000), endogenous Dvl2 staining is very similar to that seen at 1:5000 in both Dvl2
HA -expressing and -nonexpressing cells; only the staining is more robust and is ubiquitous (Fig. 1G) . In a co-labeling experiment, there is substantial overlap between the HA and the Dvl2 antibodies ( Fig. 1H-J) . We conclude that the antibody to zebrafish Dvl2 is robust and can detect endogenous Dvl2 by both western analysis and immunohistochemistry. stability of endogenous Dvl2 during zebrafish development as well as in the presence of Nkd1. First, endogenous Dvl2 protein levels were assayed over a 3-h period in the presence of cycloheximide (chx), a protein synthesis inhibitor starting at dome stage (4.3 hours postfertilization [hpf]). Over this period, Dvl2 protein levels did not diminish to any noticeable degree ( Fig. 2A) . A 4-5-h exposure of zebrafish blastula to chx was lethal, so longer assays were not feasible. The stability of Dvl2 is further emphasized by the MO knockdown studies. Within the first 18 h of development, increasing concentrations of a translation blocking Dvl2 MO had no effect on the levels of Dvl2, either by western analysis or by immunohistochemistry (not shown). Only after 24 hpf could a dose-dependent decrease in Dvl2 proteins be observed (Fig. 1C, D) . As this Dvl2 MO blocks protein translation, this suggests that Dvl2 proteins are very stable in the early zebrafish embryo.
To determine the effect of Nkd1 on Dvl2 protein levels, we first wanted to determine the changes in Nkd1 myc protein levels without chx treatment over time. As expected, the levels of protein increased with continued mRNA translation, but after 6.75 hpf, levels started to decrease (Fig. 2B) . The ability of Nkd1 to effectively inhibit Wnt signaling is dependent on an N-terminal myristoylation sequence. 5, 9 Mutating the second glycine to alanine (G2A) dramatically reduces the ability of Nkd1 to inhibit Wnt signaling. 9 Similar to Nkd1 myc , the levels of Nkd1
G2A-myc protein levels decrease over time, but in a manner that appears different than Nkd1 myc ( Fig. 2B, C ). This experiment has been repeated with different time points and different epitopes with similar conclusions. This apparent difference in stability between Nkd1 myc and Nkd1
G2A-myc cannot be attributed to differential mRNA degradation, as the injected mRNA levels were similar between Nkd1 myc and Nkd1
G2A-myc over time as detected by reverse transcription (RT)-polymerase chain reaction (PCR) (Fig. 2D , E).
Nkd1 does not destablize Dvl2
Nkd proteins are predicted to act at the level of Dvl and one hypothesis is that Nkds destabilize Dvl, preventing further Wnt signaling. 1, 2 To test this hypothesis and determine if Nkd1 affects Dvl2 protein stability, Nkd1 myc mRNA was injected into embryos and the levels of Nkd1 myc and endogenous Dvl2 were assayed in the presence of chx. A near-linear decrease in Nkd1 myc protein levels (half life ¼ 1.8 h) over 3 h of chx treatment was observed, whereas no changes were observed in endogenous Dvl2 protein levels over the same time period (Fig. 3A) . It is possible that Nkd1 myc only affects a small pool of Dvl2 that is undetectable by our methods. Such phenomena have been described previously. 10, 17, 20 To determine if Nkd1 altered exogenous Dvl2 protein levels, or if exogenous Dvl2 altered Nkd1 protein levels, we co-injected Nkd1 myc and Dvl2 HA mRNAs and assayed for protein levels over a 3-h period in the presence of chx. Similar to endogenous Dvl2, no significant difference in the degradation of Dvl2 HA in the presence or absence of Nkd1 myc was observed ( Fig. 3B-D) . Furthermore, excess Dvl2
HA did not significantly increase the degradation rate of Nkd1 myc (half life ¼ 1.70; Fig.  3C , E). To determine if there is an effect at later embryonic stages, we performed a similar assay at 80% epiboly (but without chx treatment) when there is significant Wnt signaling patterning the anterior-posterior neuroectoderm. 11, 13 We harvested embryos from the same set of injections at 30% and again at 80% epiboly and compared the levels of Dvl2 HA with and without Nkd1 myc at these two time points (Fig. 3F, G) . At 80% epiboly we observed an approximately 50% decrease in the levels of Dvl2 HA , in both the Dvl2 HA injected alone or Dvl2
HA co-injected with Nkd1 myc (Fig. 3F, G) . We also did not observe any changes in the levels of endogenous Dvl2 (Fig.  3F) . Thus, we conclude that Nkd1 does not destabilize Dvl2 at several stages of early zebrafish development.
In a previous study it was demonstrated that an intact myristoylation sequence was required for the ability of Nkd2 to degrade Dvl1 and that Nkd2
G2A was more stable than Nkd2 wild type. 3 In zebrafish, Nkd2 G2A is also at least as stable as wild-type Nkd2 (unpublished). However, evidence with Nkd1 G2A in zebrafish suggests the opposite: Nkd1 G2A is less stable than Nkd1 (Fig. 2B, C , and actin over the same time points as the western data. An uninjected sample at 3.0 hpf was used as a negative control. (E) The relative levels of nkd1 or nkd1 G2A were corrected against the levels of actin and then plotted relative to 3.0 hpf, which was arbitrarily set to 1.0. chx, cycloheximide.
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10%-15% of the protein remaining after 1 h of chx treatment (Fig. 4A, B) . This experiment has been repeated with different time points and different epitopes with similar results and in fact it is often difficult to detect any Nkd1 G2A protein after 1 h of chx exposure. Exogenous Dvl2 HA had no effect on the stability of Nkd1 G2A-GFP , nor was there any effect of Nkd1 G2A-GFP on the stability of Dvl2 HA or endogenous Dvl2 (Fig. 4B , C and not shown). However, with such a rapid rate of Nkd1 protein were plotted (G) relative to 30% epiboly, which was arbitrarily set to 1.0. Anti-Dvl2 staining suggests that endogenous Dvl2 levels are not altered by Nkd1 at mid-gastrula stages. Note: While endogenous Dvl2 appears as a single molecular weight, exogenous Dvl2
HA often appears as a doublet, the resolution of which is dependent on the gel concentration and running conditions. Error bars represent standard error from N ¼ 3 experiments.
FIG. 4. Nkd1
G2A-GFP is very unstable. (A-C) Onecell stage embryos were injected Nkd1 G2A-GFP mRNA (A) or both Dvl2
HA and Nkd1 G2A-GFP mRNA (C) and at dome stage (4.3 hpf; t ¼ 0) embryos were incubated in 50 mg/mL of chx for a further 3 h and harvested every 60 min for western analysis with anti-GFP, anti-HA, and anti-actin. The adjusted levels of Nkd1 G2A-GFP (B) were plotted relative to t ¼ 0, which was arbitrarily set to 1. This experiment was repeated 2Â with very similar results.
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of Nkd1 G2A-GFP decay suggests that either membrane association of Nkd1 confers stability or converting the second amino acid glycine to alanine makes proteins like Nkd1 G2A highly unstable.
21
Nkd1 degradation is mediated by poly-ubiquitinmediated proteosome degradation
To determine if Nkd1 is degraded by ubiquitin-mediated proteosome degradation, Nkd1 myc or Nkd1 G2A-myc mRNA, together with Ub -HA mRNA, was injected into zebrafish embryos and immunoprecipitated with anti-myc and western blotted for anti-HA. These experiments were carried out in the presence or absence of a proteosome inhibitor cocktail. These results demonstrated that wild-type Nkd1 was efficiently labeled with ubiquitin, the levels of which increased in the presence of proteosome inhibitors (Fig. 5) . Consistent with the chx treatments, this suggests that Nkd1 is efficiently turned over by ubiquitin-mediated proteolysis. In contrast, the levels of poly-ubiquitin-labeled Nkd1 G2A-myc were substantially lower despite its apparently more rapid rate of decay when compared to wild-type Nkd1 (Fig. 5) . Also, when the western blot was probed with anti-myc, the levels of Nkd1 myc and Nkd1 G2A-myc are similar in the presence of proteosome inhibitors and the levels of Nkd1 G2A increased in the presence of the proteosome inhibitors ( Fig. 5 IP: a-myc; WB: a-myc lanes 2 and 4). This suggests that Nkd1 G2A degradation is mediated via the proteosome, but why there is less Ub -HA staining relative to wild-type Nkd1 is unclear, when in fact, higher levels of Nkd1
G2A labeled with Ub -HA were expected. One possibility is that Nkd1
G2A is mono-ubiquitinated, the levels of which could not be detected on this western blot.
Discussion
The effect of Nkd1 on Dvl2 protein levels in the early zebrafish contrasts with recent findings on the effect of Nkd2 and Dvl1 in culture, where it was found that Nkd2 and Dvl1 form a mutual destruction complex and enhance each other's degradation. 3 Also, Nkd1 was found to regulate Dvl1 levels through the PP2A regulatory b-subunit PR72. 1 This suggests that Nkds may destabilize Dvl1, but the current study suggests that Nkd1 does not affect Dvl2 levels during early zebrafish development. This observation is likely due to differences in Dvl stability in these different models. In the aforementioned studies, there are changes in endogenous Dvl levels as observed by siRNA experiments, either targeting Dvl1 itself or Nkd1 and observing the effect on endogenous Dvl levels. 1, 3 We also observed an effect of Dvl2 knockdown at 1 day postfertilization (dpf). Thus, it is likely that highly stable Dvl2 protein is a phenomenon of early zebrafish development, but the significance of this is unknown.
The short half-life of Nkd1 (1.8 h) and the turnover of the injected mRNA suggest that there is insufficient Nkd1 protein levels to affect later aspects of Wnt signaling during development. This is consistent with the lack of an Nkd1 overexpression phenotype at 1 dpf. 5 Nonetheless, Nkd1 is both necessary and sufficient to inhibit both endogenous and exogenous Wnt signaling at stages that are consistent with the current study, 5, 9 despite the lack of Dvl2 degradation. This argues that Dvl2 degradation is not a prerequisite for Nkd1 antagonism of Wnt signaling.
This study also contrasts with a recent finding in zebrafish that suggests that Nkd1 can induce the degradation of Dvl2. 2 The discrepancy between these two studies is unclear, but may be related to experimental design. In our experiments we observed that exogenous Dvl2
HA protein did decrease between 30% and 80% epiboly, but that exogenous Nkd1 myc did not enhance the rate of Dvl2 HA degradation. In summary, this study demonstrates that during early zebrafish development, Dvl2 is a ubiquitous and stable protein, which is not degraded in the presence of Nkd1. Furthermore, the half-life of Nkd1 is approximately 1.8 h, which is not significantly altered by Dvl2, but is significantly altered by the presence of an intact myristoylation sequence. This suggests that the function of Nkd proteins is either critically dependent on the environment or that Nkd1 and Nkd2 have fundamentally different properties when it comes to antagonizing Wnt signaling. Thus, at least during early zebrafish development, Nkd1 does not antagonize Wnt signaling by degrading Dvl2 proteins.
Materials and Methods
Fish maintenance
Adult zebrafish and embryos were raised at 28.58C and were staged by anatomical criteria or hours postfertilization G2A-myc mRNAs were co-injected with 200pg of Ub HA mRNA, and at 3.8 hpf (sphere stage) half of the embryos were treated with proteosome inhibitors (P.I.) for 2 h with the other half being controls. At 5.8 hpf cells were lysed and proteins were immunoprecipitated with anti-myc antibodies, western blotted, and probed with anti-HA or anti-myc (top two panels). Before incubation with anti-myc, a sample of whole cell lysate was removed for analysis with anti-HA, anti-myc, and antiactin (bottom set of panels).
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according to Kimmel et al. 22 All experiments were performed in accordance with local, provincial, and federal guidelines and regulations (Animal Use Protocol no. 08R109).
Constructs
For pCS2þUbÀHA the tandem UbÀHA (8Â) fragment was isolated from pMT123 (kindly provided by Dr. Michael Freeman, Vanderbilt University) by an NotI-EcoRI double digest, blunt ended and ligated into pCS2þ digested with StuI. pCS2þNkd1 myc has been previously described 5 
mRNA injections
Capped mRNA was synthesized using Ambion's mMessage mMachine kit. After transcription, the RNA was purified over a G-50 sephadex column (Roche) or with the Megaclear kit (Ambion) and diluted in RNase free water, and its quantity and quality was analyzed as described above. The RNA was pressure injected at a final concentration of 800 ng/mL nkd1 myc or nkd1 GFP ; 1200 ng/mL of nkd1 G2A-myc or nkd1 G2A-GFP ; 200 ng/ mL UbÀHA in 1% phenol red into the yolk cell of one or twocell stage embryos.
RT-polymerase chain reaction
At least 15 embryos from each time point were snap-frozen in liquid nitrogen in the presence of 500 mL of Trizol. Total RNA was extracted using manufacturers guidelines and converted to cDNA using Superscript III (Invitrogen). PCR primers to Nkd1 (5 0 -GAAGCGCTGCACTACAGG-3 0 ) and the T7 promoter of pCS2þ (5 0 -TAATACGACTCACTATAG-3 0 ) were used for both exogenous Nkd1-and Nkd1 G2A -injected embryos. Actin (For: 5 0 -ATGCCCCTCGTGCTGTTTT-3 0 ; Rev: 5 0 -TCTGTCCCATGCCAACCAT-3 0 ) was used as a loading control. Standard PCR conditions were carried out over 30 cycles and loaded onto a 1% gel for electrophoresis.
Immunohistochemistry
Injected embryos were fixed at 30% epiboly in 4% PFA overnight at 48C, washed four times in 1Âphosphate-buffered saline (PBS) with 0.1% Tween20, incubated for 1 h at RT in block (5% goat serum, 5 mg/mL bovine serum albumin, 2% dimethyl sulfoxide [DMSO], 0.1% Tween20 in 1Â PBS), and incubated with primary antibody in block overnight at 48C. After primary incubation, embryos were washed 6Âin 1ÂPBS with 0.1% Tween20 and 2% DMSO, incubated in secondary in block for 3 h at RT, washed 6Â in 1Â PBS with 0.1% Tween20 and 2% DMSO, put into 50% glycerol/PBS, deyolked, and mounted on slide with raised coverslip.
Primary antibodies used were Rat anti- 
Cycloheximide treatments
Approximately 50-60 injected and well-developing embryos were dechorionated at sphere stage (3.8 hpf) in 0.3Â Danieau. About 50 mM Chx (BioShop Canada) in 2% DMSO, 0.3Â Danieau was preheated to 28.58C. At dome stage (4.3 hpf) embryos were placed in preheated Chx solution (except for 10 embryos, which were used for t ¼ 0) and incubated at 28.58C. Every 45 or 60 min, 10 embryos were removed and deyolked at room temp in 0.3Â Danieau, put into 100 mL of RIPA buffer containing protease inhibitors, triturated 10 times with P100 pipettor, and stored on ice for 1 h, after which an equal volume of 2 Â dithiothreitol (DTT) sample buffer was added. Samples were boiled for 5 min, centrifuged at 16,000 g for 1 min, and stored at À208C for western analysis. Approximately 20 mL of lysate (equivalent of one embryo) was loaded on an 8% acrylamide gel. with Complete Protease Inhibitior Ò (Roche) was added. Approximately 10-15 pulses with a power pestle was used to disrupt chorions and cell membranes. To further disrupt membranes, lysates were triturated with a 1.5-inch 18-gauge syringe 8 to 10 times. Another 500 mL of Rubenfelds buffer containing Complete Protease Inhibitor was added to lysate. Intact nuclei, large cell membrane fragments and chorion were pelleted by centrifugation at 960 g for 5 min at 48C. The top 900 mL was moved to a fresh 1.5 mL tube. Two hundred microliters of modified Rubenfelds buffer containing Complete Protease Inhibitor was added to obtain a final concentration of one embryo/20 mL. Aliquots of 350 mL were placed into three tubes (equivalent of 17.5 embyros). The remaining 50 mL was used for input analysis. Then, 4 mL of anti-myc (Vanderbilt Antibody Core) antibody was added to one tube and incubated at 48C overnight with gentle agitation. The following day, 25 mL of washed Sepharose Protein G (GE Healthcare) beads were added to the precipitates and incubated for another 4 h at 48C. The Protein G mixture was centrifuged at 960 g for 30 s and the beads were washed 3 Â with IP Wash Buffer (20 mM Tris, pH 8.0; 150 mM NaCl; 0.3% NP-40). Pellets were resuspended in 25 mL of 2Â DTT sample buffer (100 mM Tris-HCl pH 6.8; 200 mM DTT; 4% sodium dodecyl sulfate; 20% gyclerol; 0.2% Bromophenol blue), boiled for 5 min, centrifuged at 16,000 g for 1 min, and either stored at À208C or 20 mL was loaded for Western analysis.
Proteosome inhibitors and immunoprecipitations
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